.The confetti is still soaring coming from Eli Lilly's event commemorating the approval of Alzheimer...
.Accept to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Observing a bad showing for Lykos Rehabs' MDMA prospect for trauma at a recent FDA advising board a...
.AN2 Rehabs is reassessing its company in reaction to poor midphase records, pledging to give up hal...
.Merck & Co. is spending $700 thousand in advance to challenge Amgen in a blood stream cancer cel...
.Along With Gilead Sciences almost an FDA decision for its own liver condition medicine seladelpar, ...
.Chief executive officer David Ricks can observe the business setting up tents at basecamp responsib...
.Mattress Liquidators has actually switched Entero Therapies white as a sheet. The creditor got Ente...
.Exelixis is giving up on its cells aspect (TF)- targeting antibody-drug conjugate after ending the ...
.3 weeks after Roche's Genentech unit walked away from an SHP2 inhibitor deal, Relay Therapeutics ha...